Showing results (61-70 of 268) with videos related to
Sort By:
Pageof 27
Biomed Research International|April 5, 2013
State-of-the-art fusion-finder algorithms sensitivity and specificityMatteo Carrara, Marco Beccuti, Fulvio Lazzarato, et al.BMC Bioinformatics|December 15, 2005
An integrated approach of immunogenomics and bioinformatics to identify new Tumor Associated Antigens (TAA) for mammary cancer immunological preventionFederica Cavallo, Annalisa Astolfi, Manuela Iezzi, et al.Oncotarget|September 1, 2016
L-Ferritin targets breast cancer stem cells and delivers therapeutic and imaging agentsLaura Conti, Stefania Lanzardo, Roberto Ruiu, et al.Biomedicines|November 11, 2022
Immunotherapy against the Cystine/Glutamate Antiporter xCT Improves the Efficacy of APR-246 in Preclinical Breast Cancer ModelsGiuseppina Barutello, Antonino Di Lorenzo, Alessandro Gasparetto, et al.Advances in Immunology|May 30, 2006
Vaccination for treatment and prevention of cancer in animal modelsFederica Cavallo, Rienk Offringa, Sjoerd H van der Burg, et al.International Journal of Oncology|July 18, 2017
In vivo evaluation of tumour acidosis for assessing the early metabolic response and onset of resistance to dichloroacetate by using magnetic resonance pH imagingAnnasofia Anemone, Lorena Consolino, Laura Conti, et al.Magnetic Resonance Imaging|April 4, 2015
Cluster analysis of quantitative parametric maps from DCE-MRI: application in evaluating heterogeneity of tumor response to antiangiogenic treatmentDario Livio Longo, Walter Dastrù, Lorena Consolino, et al.Current Drug Targets|December 17, 2010
Vaccines and other immunological approaches for cancer immunopreventionPier-Luigi Lollini, Giordano Nicoletti, Lorena Landuzzi, et al.Progress in Molecular Biology and Translational Science|August 7, 2019
Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's sourceRoberto Ruiu, Lidia Tarone, Valeria Rolih, et al.International Journal of Cancer|October 8, 2008
Murine pneumotropic virus chimeric Her2/neu virus-like particles as prophylactic and therapeutic vaccines against Her2/neu expressing tumorsKalle Andreasson, Karin Tegerstedt, Mathilda Eriksson, et al.Pageof 27